Cite
Incidence of Hyperlipidemia among Adults Initiating Antiretroviral Therapy in the HIV Outpatient Study (HOPS), USA, 2007–2021.
MLA
Li, Jun, et al. “Incidence of Hyperlipidemia among Adults Initiating Antiretroviral Therapy in the HIV Outpatient Study (HOPS), USA, 2007–2021.” AIDS Research & Treatment, Nov. 2023, pp. 1–9. EBSCOhost, https://doi.org/10.1155/2023/4423132.
APA
Li, J., Agbobli-Nuwoaty, S., Palella, F. J., Novak, R. M., Tedaldi, E., Mayer, C., Mahnken, J. D., Hou, Q., Carlson, K., Thompson-Paul, A. M., Durham, M. D., & Buchacz, K. (2023). Incidence of Hyperlipidemia among Adults Initiating Antiretroviral Therapy in the HIV Outpatient Study (HOPS), USA, 2007–2021. AIDS Research & Treatment, 1–9. https://doi.org/10.1155/2023/4423132
Chicago
Li, Jun, Selom Agbobli-Nuwoaty, Frank J. Palella, Richard M. Novak, Ellen Tedaldi, Cynthia Mayer, Jonathan D. Mahnken, et al. 2023. “Incidence of Hyperlipidemia among Adults Initiating Antiretroviral Therapy in the HIV Outpatient Study (HOPS), USA, 2007–2021.” AIDS Research & Treatment, November, 1–9. doi:10.1155/2023/4423132.